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ABSTRACT
Rho family GTPases such as Cdc42 are key regulators of essential cellular processes through their
effects on cytoskeletal dynamics, signaling and gene expression. Rho GTPases modulate these
functions by engaging a wide variety of downstream effectors. Among these effectors is the largely
understudied Cdc42EP/BORG family of Cdc42 effectors. BORG proteins have been linked to actin
and septin regulation, but their role in development and disease is only starting to emerge.
Recently, Cdc42EP3/BORG2 was shown to coordinate actin and septin cytoskeleton rearrangements
in cancer-associated ﬁbroblasts (CAFs). Interestingly, Cdc42EP3 expression potentiated cellular
responses to mechanical stimulation leading to signaling and transcriptional adaptations required
for the emergence of a fully activated CAF phenotype. These ﬁndings uncover a novel role for the
BORG/septin network in cancer. Here, we demonstrate that Cdc42EP3 function in CAFs relies on
tight regulation by Cdc42.
KEYWORDS
BORG; cancer-associated
ﬁbroblasts; Cdc42EP3;
cytoskeleton; Rho GTPases;
septin
Cancer-associated ﬁbroblasts (CAFs) are stromal cells
that can inﬂuence tumor progression, dissemination and
response to therapy through remodeling of the extracel-
lular matrix (ECM) and signaling to cancer, endothelial
and immune cells.1 One major feature of CAFs is their
dramatic rearrangement of cytoskeletal networks. CAFs
are characterized by the presence of enhanced contractile
actin stress ﬁbers, upregulation of cytoskeletal compo-
nents such as smooth muscle actin (aSMA) and palladin,
and stronger focal adhesions.2-4 These changes impinge
on the capacity of CAFs to exert force and generate
invading structures, and directly affect their ability to
remodel the ECM and enable subsequent cancer cell
invasion.3-6 Force-mediated ECM remodeling by CAFs
also enhances tissue stiffness that can promote malig-
nancy by activating mechano-transduction signaling
pathways that modulate cancer cell growth, survival and
migration.7 In addition, increased actomyosin contractil-
ity in CAFs enables ﬁbroblasts to respond to changes in
matrix stiffness and leads to activation of the transcrip-
tional regulator YAP, which is critical for maintaining a
CAF phenotype.3
Rho family GTPases are key regulators of cytoskeletal
organization through their effects on actin assembly,
actomyosin contractility and microtubules, among
others.8 Rho GTPases are particularly relevant in
CAFs. RhoA activity is generally higher in CAFs com-
pared to normal ﬁbroblasts (NFs), and mediates the
phosphorylation of myosin light chain 2 (MLC2) at S19
and/or T18 via Rho-kinases ROCK1 and ROCK2. This
leads to MLC2 activation, a highly contractile cytoskele-
ton and matrix remodeling.5,6 In contrast, Rac1 is mainly
inactivated in CAFs.6 Importantly, modulating the bal-
ance of RhoA/Rac1 signaling has been shown to signiﬁ-
cantly affect CAF functions.3,5,6 In addition, Cdc42
signaling through its effectors MRCKa and b can also
generate actomyosin contractility, through direct phos-
phorylation of MLC29-11 and activation of Cdc42 can
also promote the formation of matrix-degrading invado-
podia in CAFs leading to enhanced tumor cell invasion.4
Based on the well-established links between cytoskele-
tal organization and CAF functions, we recently con-
ducted a study to identify novel regulators of CAFs by
performing an RNAi loss-of-function screen of cytoskel-
eton-related factors.12 Using NFs and CAFs isolated
from a murine model of breast cancer, the transgenic
FVB/n strain expressing the polyoma middle T antigen
oncogene under the mouse mammary tumor virus pro-
moter (MMTV-PyMT),3 we compared their cytoskeletal
organization and observed that this model recapitulates
most of the characteristics of CAFs. Compared to NFs,
CAFs had enhanced F-actin stress ﬁbers containing
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active MLC2, abundant paxillin-positive focal adhesions
and up-regulation of aSMA (Fig. 1A). We also explored
other cytoskeletal networks and observed no obvious dif-
ferences in the organization of intermediate ﬁlaments
and microtubules between NF and CAFs (Fig. 1B). Sep-
tins are increasingly recognized as cytoskeletal compo-
nents, due to their ability to (i) assemble into oligomeric
complexes (such as the well characterized SEPT2/6/7
heterotrimer); (ii) form higher-order structures such as
ﬁlaments and rings; and (iii) associate with cellular
membranes, actin ﬁlaments and microtubules.13,14 Inter-
estingly, our analyses showed that CAFs presented more
extensive septin networks (Fig. 1C) that generally co-
aligned with actin stress ﬁbers (Fig. 1D), describing a
novel cytoskeletal characteristic of CAFs.
Our screen identiﬁed Cdc42 effector protein
3 (Cdc42EP3)/BORG2 as a key regulator of CAFs.12
Using biochemical approaches and super-resolution
microscopy we demonstrated that Cdc42EP3 can inde-
pendently bind F-actin and septins, localizes at the
interface between F-actin ﬁbers and SEPT2 ﬁlaments
and stabilizes both networks in CAFs. In addition, we
observed a particular pattern of SEPT2 and Cdc42EP3
localization between stress ﬁbers suggesting that they
could provide mechanical support for the contractile
actin cytoskeleton. In agreement, depletion of
Cdc42EP3 or SEPT2 led to the full disruption of acto-
myosin ﬁbers and loss of focal adhesions. The main
consequence was a drastic functional inactivation of
CAFs, as Cdc42EP3-depleted CAFs presented reduced
matrix remodeling, cancer cell invasion, angiogenesis
and tumor growth promoting abilities, a phenotype
that was mimicked by SEPT2-depletion.
Gain-of-function analyses demonstrated that
ectopic expression of Cdc42EP3 in NFs could induce
the formation of F-actin ﬁbers and septin ﬁlaments,
reminiscent of CAF-like cytoskeletal rearrangements.
Interestingly, direct binding of Cdc42EP3 to both F-
actin and septins was required to drive both networks
into a ﬁlamentous state. We observed that a Cdc42-
Figure 1. Cytoskeletal networks in normal mammary ﬁbroblasts (NFs) and MMTV-PyMT derived breast CAFs (CAFs). (A) Left panels show
images of F-actin (magenta), pS19-MLC2 (green) and DAPI (blue). Middle panels show F-actin (magenta), paxillin (green) and DAPI
(blue) staining. Right panels show F-actin (magenta), aSMA (green) and DAPI (blue) staining. Scale bars represent 20 mm. (B) Left panels
show images of F-actin (magenta), vimentin (green) and DAPI (blue). Right panels show F-actin (magenta), acetylated tubulin (green)
and DAPI (blue) staining. Scale bars represent 20 mm. (C) Images show SEPT2 (green), SEPT7 (magenta) and DAPI (blue) staining.
A zoom up area is shown for CAFs. Scale bars represent 20 mm. (D) Images show staining of F-actin (magenta), SEPT2 (green) and DAPI
(blue) in CAFs. A zoom up area for F-actin and SEPT2 is shown. Scale bar represents 20 mm.
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binding defective mutant of Cdc42EP3 (Cdc42EP3-IS)
could not interact with actin in co-immunoprecipita-
tion assays.12 Here, we further examined the localiza-
tion and activity of this mutant and the role of
Cdc42 in modulating Cdc42EP3 functions in NFs and
CAFs.
When expressed in NFs, Cdc42EP3-IS presented a
diffuse cytosolic localization, in striking contrast to
the ﬁlamentous appearance of wild-type Cdc42EP3
(Fig. 2A and B). In addition, this Cdc42-binding
defective mutant was no longer able to induce F-actin
and septin reorganization. Cdc42EP3-IS mislocalization
was also evident in CAFs, which present increased
basal levels of F-actin and ﬁlamentous septin, thus
ruling out any requirement of F-actin/ﬁlamentous
septin structures for the correct positioning of this
mutant (Fig. 3A and B). On the contrary, Cdc42EP3-
IS appeared to act as a dominant-negative mutant as
both actin stress ﬁbers and particularly SEPT2 ﬁla-
ments were amply diminished in CAFs following
Cdc42EP3-IS transfection (Fig. 3A and B). In agree-
ment, expression of Cdc42EP3-IS in CAFs resulted in
reduced pS19-MLC2 staining and fewer paxillin-posi-
tive focal adhesions (Fig. 3C). This phenotype was
very similar to that observed following Cdc42EP3
depletion.12
To further investigate the role of Cdc42 in regulating
Cdc42EP3 functions, we monitored Cdc42EP3 localiza-
tion and actin/septin rearrangements in CAFs after
expression of Cdc42-N17 and Cdc42-V12, dominant
negative and constitutively active mutant versions of
Cdc42, respectively. Inhibiting Cdc42 function by tran-
sient expression of the dominant negative Cdc42-N17
protein resulted in a loss of ﬁlamentous Cdc42EP3 struc-
tures and reduced F-actin stress ﬁbers and ﬁlamentous
SEPT2 (Fig. 4A and B). However, boosting Cdc42 activ-
ity by transient expression of the constitutively active
mutant Cdc42-V12 did not potentiate Cdc42EP3 activity.
On the contrary, expression of Cdc42-V12 sequestered
Cdc42EP3 to Cdc42-V12-rich vesicles and resulted in a
complete loss of ﬁlamentous Cdc42EP3 (Fig. 4A and B).
Cdc42-V12 expression also led to reduced levels of peri-
nuclear F-actin ﬁbers and SEPT2 ﬁlaments. These ﬁnd-
ings are in agreement with previous studies showing that
the function of the closely related protein Cdc42EP5
over septins is negatively regulated by constitutively
active Cdc42.15 In general, these data suggest that the
coordinating function of Cdc42EP3 over F-actin and sep-
tins depends on Cdc42, which regulates the correct posi-
tioning of Cdc42EP3 and its ability to form ﬁlaments.
However, this process relies on the ability of Cdc42 to
cycle between active and inactive states. If Cdc42 is
Figure 2. A Cdc42-defective binding mutant of Cdc42EP3 presents a diffuse pattern of cytosolic localization and does not induce actin
and septin rearrangements in normal ﬁbroblasts. (A) Panels show GFP (green), F-actin (magenta) and DAPI (blue) staining of normal
ﬁbroblasts following transfection with GFP or GFP-tagged wild-type (wt) or IS mutant (IS) Cdc42EP3 (CEP3) proteins. The grayscale pan-
els show individual channels for F-actin and GFP. Scale bars, 25 mm. (B) Panels show GFP (green), SEPT2 (magenta) and DAPI (blue)
staining of normal ﬁbroblasts following transfection with GFP or GFP-tagged wild-type (wt) or IS mutant (IS) Cdc42EP3 (CEP3) proteins.
The grayscale panels show individual channels for F-actin and GFP. Scale bars, 25 mm.
SMALL GTPASES 3
locked in an active state (like in the case of the constitu-
tively active mutant Cdc42-V12), Cdc42EP3 is also
severely affected. Whether Cdc42-V12 localization is not
ideal for the correct positioning of Cdc42EP3 or whether
the transition between active/inactive Cdc42 is required
for Cdc42EP3 functions (i.e. for releasing it and allowing
other essential molecular interactions) are details still to
be determined.
Septin ﬁlament assembly can follow an actin tem-
plate by means of adaptor proteins.16 Our study dem-
onstrated that Cdc42EP3 depletion reduced the
ﬁlamentous septin network in CAFs,12 an effect that
was also detected after blocking stress ﬁber formation
by depleting the well-known actin remodeling proteins
DIAPH1 and DIAPH3.17 Recently, it has been shown
that SEPT9 can bind F-actin and promote the
cross-linking of preassembled actin ﬁlaments,18,19
underlying the notion of a functional inter-relation-
ship between both networks. Our data suggested that
Cdc42EP3 may act as a ‘molecular bridge’ between
septin ﬁlaments and F-actin ﬁbers that reinforces both
networks.12 In CAFs, this interaction may allow the
“template function” of actin needed for septin poly-
merization, as well as potentiating the F-actin
cross-linking activity of septins. Still to be determined
is whether Cdc42EP3 presents intrinsic septin and
F-actin polymerization/cross-linking activities that
could also explain these observations.
We also observed that Cdc42EP3 and SEPT2 organi-
zation changes in response to substrate stiffness in
CAFs.12 Moreover, Cdc42EP3 and septin ﬁlaments were
required and in part sufﬁcient for CAFs to respond to
mechanical stimulation and activate the key regulator
YAP, indicative of a novel molecular role for these pro-
teins in mechano-transduction. Our data suggested that
Cdc42EP3 and septins perform this function by reinforc-
ing the contractile actin cytoskeleton, thus allowing for
increased isometric tension in CAFs. Further studies are
needed to determine whether Cdc42EP3 and septins can
regulate mechano-transduction per se or via alternative
actomyosin-independent mechanisms.
These properties and functions may not be exclusive
of Cdc42EP3 in CAFs. Filamin A (FLNA) is a cytoskele-
tal protein that organizes ﬁlamentous actin in networks
Figure 3. A Cdc42-defective binding mutant of Cdc42EP3 acts as a dominant-negative when expressed in cancer-associated ﬁbroblasts
(CAFs). (A) Panels show GFP (green), F-actin (magenta) and DAPI (blue) staining of cancer-associated ﬁbroblasts (CAFs) following trans-
fection with GFP or GFP-tagged wild-type (wt) or IS mutant (IS) Cdc42EP3 (CEP3) proteins. The grayscale panels show individual channel
magniﬁcations of perinuclear areas. Scale bars, 25 mm. (B) Panels show GFP (green), SEPT2 (magenta) and DAPI (blue) staining of CAFs
following transfection with GFP or GFP-tagged wild-type (wt) or IS mutant (IS) Cdc42EP3 (CEP3) proteins. The grayscale panels show
individual channel magniﬁcations of perinuclear areas. Scale bars, 25 mm. (C) Left panels show images of GFP (green), pS19-MLC2
(magenta) and DAPI (blue) staining of CAFs following transfection with GFP or GFP-tagged wild-type (wt) or IS mutant (IS) Cdc42EP3
(CEP3) proteins. Right panels show GFP (green), pY118-Paxillin (magenta) and DAPI (blue) staining of CAFs following transfection with
GFP or GFP-tagged wild-type (wt) or IS mutant (IS) Cdc42EP3 (CEP3) proteins. Scale bars represent 25 mm.
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and stress ﬁbers,20 binds to SEPT921 and participates in
mechano-sensing.22 Anillin (ANLN) is an adaptor pro-
tein that mediates septin assembly following an actin
template during cytokinesis.16 Accordingly, perturbing
ANLN function or septin organization results in attenua-
tion of actin stress ﬁbers in NIH3T3 ﬁbroblasts.16 Both
FLNA and ANLN were found to be upregulated in CAFs
and were evaluated in our RNAi screen.12 Only FLNA
depletion seemed to affect CAF functionality, albeit to a
lesser extent than Cdc42EP3. It will be interesting to fur-
ther investigate whether FLNA plays similar roles to
Cdc42EP3 in CAFs or whether it coordinates alternative
mechanisms.
Other related proteins may operate in a similar
fashion to Cdc42EP3. Cdc42EP3 is a member of the
BORG/Cdc42EP family of Cdc42 effectors, which
comprises of 5 members (Fig. 5A).23,24 Noteworthy,
Cdc42EP3 was the only BORG protein that presented
differential expression between NFs and CAFs;12 this
may be different in other systems. BORG proteins
share a Cdc42/Rac interactive binding (CRIB) motif
that allows the interaction with active Cdc42 and
RhoQ/TC10 but not RhoA or Rac1.23-25 The deﬁning
characteristic of BORG proteins is the presence of 3
BORG speciﬁc domains (BD1-3). The BD3 domain is
present in all members and mediates the interaction
between BORG proteins and septin complexes
(Fig. 5B),15,26 allowing BORGs to regulate septin orga-
nization in mammalian cells.15,23 In addition, ectopic
expression of BORGs leads to changes in cell shape
Figure 4. Modulating the activity of Cdc42 in CAFs affects Cdc42EP3 localization and septin and F-actin organization. (A) Panels show
GFP (green), F-actin (magenta) and myc (blue) staining of cancer-associated ﬁbroblasts (CAFs) stably expressing Cdc42EP3-GFP following
transfection with empty vector, myc-Cdc42-N17 or myc-Cdc42-V12. The grayscale panels show individual channels as indicated. Scale
bars, 25 mm. (B) Panels show GFP (green), SEPT2 (magenta) and myc (blue) staining of cancer-associated ﬁbroblasts (CAFs) stably
expressing Cdc42EP3-GFP following transfection with empty vector, myc-Cdc42-N17 or myc-Cdc42-V12. The grayscale panels show indi-
vidual channels as indicated. Scale bars, 25 mm.
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and the formation of F-actin containing structures
and pseudopodia,23-25 suggesting that other BORG
proteins may also bind and modulate F-actin net-
works. In endothelial cells, Cdc42EP1 in conjunction
with septins, promotes angiogenesis by regulating per-
sistent directional migration through spatial control of
actomyosin contractility,27 a function reminiscent of the
one performed by Cdc42EP3 in CAFs. We observed
that the binding of Cdc42EP3 to F-actin was dependent
on a speciﬁc motif that is not widely conserved across
the family (Fig. 5C). This suggests that BORGs may
modulate actin networks by alternative mechanisms.
One possibility is that the activity of BORGs over actin
may also depend on their modulatory role over septins,
that may affect F-actin polymerization directly18 or via
adaptor proteins.16 Alternatively, this activity may be
mediated in other BORGs by different domains or via
alternative modes of action that still need to be fully
characterized. For example, PKC-mediated phosphory-
lation reduces the afﬁnity of Cdc42EP4 to Cdc42 in
MCF-10A cells. This allows binding to the Rac-GEF
ARHGEF17, resulting in Rac1 activation, altered actin
containing structures and cell migration.28 In addition,
ectopic expression of Cdc42EP5 in NIH3T3 ﬁbroblasts
Figure 5. The Cdc42EP/BORG family of Cdc42 effectors. (A) Schematic showing the different BORG protein domains. (B) The BORG
homology 3 (BD3) domains of Cdc42EP1-5, with conserved residues in red. Key residues within that region are underlined. (C) Direct
alignments of the putative actin binding domain of Cdc42EP3, in comparison with other BORGs. This domain is absent in Cdc42EP5.
Conserved residues are in red, key residues are underlined. (D) Model outlining the role of Cdc42EP3 and septins in the emergence of
CAFs. Tumor cell-derived soluble factors promote the upregulation of Cdc42EP3 expression in NFs. This results in an altered cytoskeletal
network with increased septin-actin cohesion and isomeric tension. As a result, cellular responses to mechanical stimulation are potenti-
ated, leading to signaling and transcriptional adaptations (e.g. YAP activation) required for the emergence of a fully activated CAF phe-
notype. (Right) Immunoﬂuorescence of the perinuclear region in CAFs, showing co-localization of Cdc42EP3 (green), F-actin (magenta)
and SEPT2 (yellow).
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leads to RhoA inhibition and loss of stress ﬁbers in a
mechanism that is independent of Cdc42 binding.23 We
ﬁnd these functional interactions particularly intriguing
as they suggest that, despite not having any direct link
with other Rho GTPases,23 BORG proteins can still
modulate their activity and functions.
Interestingly, Cdc42EP3 was required for the tran-
sition from a NF to a highly contractile CAF. We
also observed that Cdc42EP3 upregulation occurred
early during ﬁbroblast activation in cancer in
response to multiple factors, including HGF, TGFb,
and SDF-1a. Both chemical and mechanical stimula-
tion are suggested to be responsible for the pathologi-
cal activation of ﬁbroblasts.29 Our model (Fig. 5D)
suggests that Cdc42EP3 is located at a key node link-
ing both activating processes. We propose that
Cdc42EP3 expression induced by cancer cells or
inﬂammatory signals in the stroma of pre-malignant
lesions would sensitize ﬁbroblasts to respond to
changes in the physical environment. These changes
would enable the subsequent activation of mechano-
transduction signaling pathways needed for the emer-
gence of a fully activated CAF.
The linking and reinforcement of actin and septin
networks may be also critical in other contexts. In
cancer, actin polymerization and actomyosin contrac-
tility are key events in migratory tumor cells and
metastasis.30 The activation of mechano-responsive
signaling pathways can also promote malignancy by
enhancing cancer cell growth, survival and migration.7
In addition, SEPT9 has been shown to be essential for
pseudopod protrusion and tumor cell migration and
invasion by promoting the cross-linking of lamellar
stress ﬁbers and the stability of nascent focal adhe-
sions.18,31 In a physiological context, septins have been
shown to regulate lymphocyte trafﬁcking in conﬁned
tissues by tuning actomyosin forces during motility.32
Whether BORGs also play a role in these settings is an
interesting possibility worth exploring.
To conclude, our study demonstrated that CAFs
represent a powerful tool to investigate cytoskeletal
regulation in a biologically relevant setting. We
uncovered a critical role for the coordination of actin
and septin networks in CAFs. Disrupting this coordi-
nated interaction prevented the activation of
mechano-sensing signaling pathways, including paxil-
lin, Src and YAP. CAFs have been shown to partici-
pate in many of the hallmarks of cancer and are
being suggested as potential therapeutic targets.1 Pre-
venting F-actin and septin coordination largely
impacts the pro-tumorigenic properties of CAFs,
diminishing their force-mediated matrix remodeling,
cancer cell invasion, angiogenesis, and tumor growth
promoting abilities. We identiﬁed Cdc42EP3 as a crit-
ical regulator of these activities, through tight regula-
tion by Cdc42. Whether targeted disruption of
Cdc42EP3 function represents a therapeutic opportu-
nity to deactivate CAFs, is an enticing possibility that
merits further investigation.
Materials and methods
cDNAs
Murine Cdc42EP3 cDNAs have been previously
described. Brieﬂy, Cdc42EP3 cDNA from pCMV-Sport-
6-Cdc42EP3 was subcloned into pEGFP.C1 backbone.
pEGFP-Cdc42EP3 was used as a template to generate
the mutant Cdc42EP3(IS-AA) using the GeneArt Site-
Directed Mutagenesis PLUS kit (Life Technologies).
Sequences of the degenerated oligonucleotides can be
provided on request. GFP-Cdc42EP3 was also subcloned
in the pCSII-IRES lentiviral system that was used to gen-
erate stable cells lines. Plasmids encoding myc-tagged
Cdc42 N17 and V12 mutants were a gift from Erik Sahai
(Crick Institute, London, UK).
Cell lines
Fibroblasts from normal mammary glands (NFs) and
mammary carcinoma (CAFs) have been previously
described.3 Brieﬂy, normal mammary glands and mam-
mary carcinoma tissue (12 week-old females) from
MMTV-PyMT mice were dissected. Fibroblasts were iso-
lated and immortalized with the HPV-E6 virus followed
by selection on 2.5 mg/mL puromycin.33 Resulting popula-
tions were assessed for ﬁbroblast and CAF marker expres-
sion and thoroughly characterized.3 All ﬁbroblasts were
cultured in DMEM (Invitrogen) 10% FBS, 1% insulin-
selenium-transferrin (ITS). Cell lines stably expressing
Cdc42EP3-GFP were generated by lentiviral infection.
Transfections
Fibroblasts were cultured in standard conditions and
seeded at a density of 1.5 £ 105 cells/ml in a 6-well plate
the day before transfection. cDNA transfection was per-
formed using Lipofectamine 3000 reagent (Life Technol-
ogies) for all plasmids as per supplier’s instructions.
Immunoﬂuorescence
Cells were usually ﬁxed in 4% paraformaldehyde for 1 h.
For the analysis of endogenous septins, cells were ﬁxed
in ice-cold methanol for 10 min. Cells were permeabi-
lized by incubation in PBS 0.5% NP-40 (Sigma) at 4C
for 20 min (twice), in PBS 0.3% Triton 100 (Sigma) at
room temperature (RT) for 20 min and in PBS 0.1% Tri-
ton 100 at RT for 15 min (twice). Samples were blocked
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for 60 min at RT (twice) in blocking solution: 4% BSA
PBS 0.05% Tween20 (Sigma). Then, cells were incubated
with primary antibody in blocking solution in a wet
chamber overnight at 4C. After 3 washes of 15 min in
PBS, secondary antibody in blocking solution was added
for 3 h. After 3 washes of 15 min in PBS, samples were
mounted and analyzed using an inverted Zeiss LSM780
confocal microscope. Antibody description and working
dilutions are: Acetylated-Tubulin (Abcam ab24610,
1:500), aSMA (Sigma A2547, 1:500), c-Myc (Cell Signal-
ing 5605, 1:100), Paxillin (Transduction labs 510051,
1:100), Phospho-Paxillin Y118 (Invitrogen 44-722G,
1:100), Phalloidin-TRITC (Sigma P1951, 1:500), Phos-
pho-MLC2 S19 (Cell Signaling, 3672, 1:100), SEPT2
(Proteintech 60075, 1:200), SEPT7 (Proteintech 13818,
1:200), Vimentin (Sigma, V2258, 1:200).
Abbreviations
aSMA smooth muscle actin, a
BD BORG speciﬁc domain
BORG binder of Rho GTPases
CAF cancer-associated ﬁbroblast
CRIB Cdc42/Rac interactive binding
ECM extracellular matrix
GEF guanine nucleotide exchange factor
HGF hepatocyte growth factor
MMTV-PyMT mouse mammary tumor virus – poly-
oma-middle T antigen
NF normal ﬁbroblast
SDF-1a stromal cell-derived factor 1 a
TGFb transforming growth factor b
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